Zarife Sahenk

Years Active: 2017-2023
Publications (10 Years): 6

This page only lists publications with an associated author ORCID identifier.

Publications

Lingying Tong, Burcak Ozes, Kyle Moss, Morgan Myers, Alicia Ridgley, Zarife Sahenk
AAV1.NT-3 gene therapy in the SOD1KO mouse model of accelerated sarcopenia. Journal of cachexia, sarcopenia and muscle (2023)
Burcak Ozes, Morgan Myers, Kyle Moss, Jennifer Mckinney, Alicia Ridgley, Lei Chen, Shasha Bai, Charles K Abrams, Mona M Freidin, Jerry R Mendell, Zarife Sahenk
AAV1.NT-3 gene therapy for X-linked Charcot-Marie-Tooth neuropathy type 1. Gene therapy (2021)
Burcak Ozes, Kyle Moss, Morgan Myers, Alicia Ridgley, Lei Chen, Darren Murrey, Zarife Sahenk
AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in GarsP278KY/+ mice. Brain communications 3 (4) (2021)
Zarife Sahenk, Mehmet E Yalvac, Jakkrit Amornvit, William David Arnold, Lei Chen, Kimberly M Shontz, Sarah Lewis
Efficacy of exogenous pyruvate in TremblerJ mouse model of Charcot-Marie-Tooth neuropathy. Brain and behavior 8 (10) (2018)
Jakkrit Amornvit, Mehmet E Yalvac, Lei Chen, Zarife Sahenk
A novel p.T139M mutation in HSPB1 highlighting the phenotypic spectrum in a family. Brain and behavior 7 (8) (2017)
Mehmet E Yalvac, Jakkrit Amornvit, Cilwyn Braganza, Lei Chen, Syed-Rehan A Hussain, Kimberly M Shontz, Chrystal L Montgomery, Kevin M Flanigan, Sarah Lewis, Zarife Sahenk
Impaired regeneration in calpain-3 null muscle is associated with perturbations in mTORC1 signaling and defective mitochondrial biogenesis. Skeletal muscle 7 (1) (2017)

Zarife Sahenk.css-eqlu8i{font-size:small;padding-left:4px;}